Healthcare provider profile · identity verified

James L Schieberl, MD

Family Practice · WOODLAND, CA · NPI 1346336005

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	696	274
Levothyroxine Sodium	Levothyroxine Sodium	384	134
Amlodipine Besylate	Amlodipine Besylate	368	145
Lisinopril	Lisinopril	354	134
Losartan Potassium	Losartan Potassium	334	131
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	291	115
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	259	59
Gabapentin	Gabapentin	212	80
Lorazepam	Lorazepam	209	60
Hydrochlorothiazide	Hydrochlorothiazide	188	80
Simvastatin	Simvastatin	180	74
Pantoprazole Sodium	Pantoprazole Sodium	178	76
Alendronate Sodium	Alendronate Sodium	160	60
Famotidine	Famotidine	157	59
Albuterol Sulfate Hfa	Albuterol Sulfate	153	83
Trazodone Hcl	Trazodone Hcl	153	57
Tamsulosin Hcl	Tamsulosin Hcl	148	56
Fluticasone Propionate	Fluticasone Propionate	147	53
Metoprolol Tartrate	Metoprolol Tartrate	143	59
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	141	52
Atenolol	Atenolol	137	51
Rosuvastatin Calcium	Rosuvastatin Calcium	112	40
Metoprolol Succinate	Metoprolol Succinate	104	40
Omeprazole	Omeprazole	104	39
Allopurinol	Allopurinol	102	38
Metformin Hcl Er	Metformin Hcl	102	45
Bisoprolol Fumarate	Bisoprolol Fumarate	95	35
Quetiapine Fumarate	Quetiapine Fumarate	95	21
Alvesco	Ciclesonide	92	33
Amoxicillin	Amoxicillin	91	48
Pradaxa	Dabigatran Etexilate Mesylate	91	31
Sertraline Hcl	Sertraline Hcl	89	39
Montelukast Sodium	Montelukast Sodium	87	31
Terazosin Hcl	Terazosin Hcl	86	32
Potassium Chloride	Potassium Chloride	84	29
Furosemide	Furosemide	78	37
Triamcinolone Acetonide	Triamcinolone Acetonide	76	46
Bupropion Xl	Bupropion Hcl	74	25
Cephalexin	Cephalexin	71	61
Zolpidem Tartrate	Zolpidem Tartrate	67	14
Meloxicam	Meloxicam	65	25
Oxycodone Hcl	Oxycodone Hcl	65	21
Acyclovir	Acyclovir	63	27
Ibuprofen	Ibuprofen	62	29
Fluoxetine Hcl	Fluoxetine Hcl	61	26
Spironolactone	Spironolactone	60	28
Venlafaxine Hcl Er	Venlafaxine Hcl	60	17
Breyna	Budesonide/Formoterol Fumarate	57	27
Clopidogrel	Clopidogrel Bisulfate	57	23
Prednisone	Prednisone	56	38
Spiriva Respimat	Tiotropium Bromide	56	22
Ondansetron Hcl	Ondansetron Hcl	53	21
Finasteride	Finasteride	51	19
Sumatriptan Succinate	Sumatriptan Succinate	49	13
Wixela Inhub	Fluticasone Propion/Salmeterol	49	14
Baclofen	Baclofen	45	12
Citalopram Hbr	Citalopram Hydrobromide	45	18
Jardiance	Empagliflozin	45	15
Estradiol	Estradiol	44	27
Mirtazapine	Mirtazapine	44	17
Acetaminophen-Codeine	Acetaminophen With Codeine	43	suppressed
Metformin Hcl	Metformin Hcl	43	20
Ropinirole Hcl	Ropinirole Hcl	43	12
Ozempic	Semaglutide	42	suppressed
Azelastine Hcl	Azelastine Hcl	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	16
Lovastatin	Lovastatin	39	17
Humulin N	Insulin Nph Human Isophane	38	19
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	37	37
Duloxetine Hcl	Duloxetine Hcl	36	14
Fluocinonide	Fluocinonide	36	23
Carvedilol	Carvedilol	35	19
Colchicine	Colchicine	35	11
Escitalopram Oxalate	Escitalopram Oxalate	35	11
Doxycycline Monohydrate	Doxycycline Monohydrate	34	26
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	suppressed
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	13
Azithromycin	Azithromycin	32	28
Ondansetron Odt	Ondansetron	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	30	12
Nortriptyline Hcl	Nortriptyline Hcl	29	13
Levetiracetam	Levetiracetam	28	suppressed
Buprenorphine	Buprenorphine	27	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	23
Donepezil Hcl	Donepezil Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	15
Glipizide Er	Glipizide	23	suppressed
Nystatin	Nystatin	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	14
Buspirone Hcl	Buspirone Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Victoza 2-Pak	Liraglutide	19	suppressed
Digoxin	Digoxin	18	11
Glipizide	Glipizide	18	suppressed
Mesalamine	Mesalamine	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metronidazole	Metronidazole	15	15
Progesterone	Progesterone, Micronized	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Eliquis	Apixaban	14	suppressed
Fluorouracil	Fluorouracil	14	12
Humulin R	Insulin Regular, Human	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Budesonide Dr	Budesonide	13	suppressed
Calcipotriene	Calcipotriene	13	11
Clonidine Hcl	Clonidine Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	13	suppressed
Oxazepam	Oxazepam	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Naproxen	Naproxen	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Retin-A	Tretinoin	11	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error